United Health Products settles SEC investigation; former CEO to disgorge $1.02M to company

United Health Products, Inc.

SEC settlement requires permanent injunctions and $450,000 civil penalty payable over 270 days.
Former CEO Douglas Beplate to pay $1,020,000 disgorgement to UHP over next six months.
CEO Brian Thom's RSU grant increased 15% to 13.225M shares; vesting upon FDA premarket approval jumps from 5% to 20%.
Independent Director Robert Denser granted 1M RSUs vesting upon $30M cumulative revenue or change of control.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.